Viable germ cell tumor (GCT) identified at postchemotherapy retroperitoneal lymph node dissection (PC-RPLND): The significance of risk assignment and adjuvant chemotherapy

被引：1
|
作者：
Karanikolas, NT
Serio, A
Vickers, AJ
Carver, BS
Stephenson, AJ
Bosl, GJ
Joel, S
机构：
来源：
JOURNAL OF UROLOGY | 2006年 / 175卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)32836-2
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
590
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [1] Retroperitoneal cancer viability after postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in good risk germ cell tumors (GCTs)
    Taza, Fadi
    Chovanec, Michal
    Snavely, Anna
    Adra, Nabil
    Hanna, Nasser H.
    Cary, Clint
    Masterson, Timothy A.
    Einhorn, Lawrence H.
    Albany, Costantine
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Need for organ preservation in postchemotherapy retroperitoneal lymph node dissection (PC-RPLND).
    Nestler, Tim
    Paffenholz, Pia
    Pfister, David
    Maatoug, Yasmine
    Che, Yue
    Hiester, Andreas
    Albers, Peter
    Heidenreich, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Need for organ preservation in Postchemotherapy Retroperitoneal Lymph Node Dissection (PC-RPLND)
    Nestler, T.
    Paffenholz, P.
    Pfister, D.
    Maatoug, Y.
    Che, Y.
    Hiester, A.
    Albers, P.
    Heidenreich, A.
    EUROPEAN UROLOGY, 2023, 83
  • [4] Complicated postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in advanced testicular germ cell tumours: Is it worth the efforts?
    Heidenreich, Axel
    Porres, Daniel
    Pfister, David J. K. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [5] The prognostic value of teratoma in the primary tumor and postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) specimens in patients with germ cell tumors (GCTs)
    Taza, Fadi
    Chovanec, Michal
    Snavely, Anna
    Adra, Nabil
    Hanna, Nasser H.
    Cary, Clint
    Masterson, Timothy A.
    Einhorn, Lawrence H.
    Albany, Costantine
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [6] IMPACT OF BLEOMYCIN ON RETROPERITONEAL HISTOLOGY AT POST-CHEMOTHERAPY RETROPERITONEAL LYMPH NODE DISSECTION (PC-RPLND) IN GOOD RISK GERM CELL TUMORS
    Cary, K. Clint
    Pedrosa, Jose
    Kaimakliotis, Hristos
    Masterson, TImothy
    Einhorn, Lawrence
    Foster, Richard
    JOURNAL OF UROLOGY, 2014, 191 (04): : E855 - E855
  • [7] Post-chemotherapy retroperitoneal lymph node dissection (PC-RPLND) for advanced nonseminomatous germ cell tumor (NSGCT): Correlation of teratoma in the primary tumor and RPLND histology
    Callegaro Filho, Donato
    Smaletz, Oren
    Mutao, Taciana Sousa
    Maia Loureiro, Luiz Victor
    Silvestro e Silva Macarenco, Ricardo
    Rosenblatt, Charles
    Alter, Wladimir, Jr.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Adjunctive surgeries in postchemotherapy retroperitoneal lymph node dissection in, PC-RPLND, patients with non seminomatous germ cell cancer, NSGCC after cisplatin based chemotherapy
    Pfister, D.
    Albers, P.
    Busch, J.
    Dieckmann, K-P
    Honecker, F.
    Krege, S.
    Winter, C.
    Schmelz, H.
    Schrader, M.
    Heidenreich, A.
    ONKOLOGIE, 2013, 36 : 114 - 114
  • [9] Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) in patients with testis cancer in the salvage setting.
    Albers, Peter
    Nini, Alessandro
    Hiester, Andreas
    Winter, Christian
    Lusch, Achim
    Lorch, Anja
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [10] Evaluation of the oncologic benefit of adjunctive surgery at time of postchemotherapy retroperitoneal lymph node dissection (PC-RPLND)
    Nestler, Tim
    Paffenholz, Pia
    Pfister, David
    Hiester, Andreas
    Nini, Alessandro
    Albers, Peter
    Heidenreich, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
12345